PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Pacific Biosciences Of California, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$60.7M, a 9.19% increase year-over-year.
  • Pacific Biosciences Of California, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$394M, a 27.5% decline year-over-year.
  • Pacific Biosciences Of California, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$307M, a 2.39% increase from 2022.
  • Pacific Biosciences Of California, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$314M, a 73.4% decline from 2021.
  • Pacific Biosciences Of California, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$181M, a 716% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$394M -$60.7M +$6.14M +9.19% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$400M -$173M -$103M -148% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$297M -$78.2M +$9.84M +11.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$307M -$82M +$2.37M +2.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$309M -$66.9M +$10.1M +13.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$319M -$69.8M +$1.56M +2.19% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$321M -$88M -$6.52M -8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$314M -$84.4M -$15.1M -21.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$299M -$77M -$93.5M -565% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$206M -$71.4M -$30.4M -74.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$175M -$81.5M +$5.94M +6.79% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$181M -$69.3M -$144M -193% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$37M $16.5M +$40.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$77.2M -$41M -$17.9M -77.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$59.3M -$87.4M -$88.7M -7028% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $29.4M $74.9M +$75M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$45.6M -$23.7M +$5.42M +18.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$51M -$23.1M +$1.51M +6.14% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$52.5M $1.26M +$31.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$84.1M -$91K +$30.7M +99.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-28
Q3 2019 -$115M -$29.1M -$4.08M -16.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$111M -$24.6M -$2.06M -9.12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$109M -$30.3M -$6.15M -25.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$103M -$30.8M -$10M -48.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$92.5M -$25M -$3.02M -13.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$89.5M -$22.5M +$3M +11.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$92.5M -$24.2M -$312K -1.31% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$92.2M -$20.8M -$1.73M -9.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$90.5M -$22M -$4.53M -25.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 -$85.9M -$25.5M -$7.04M -38.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 -$78.9M -$23.9M -$4.52M -23.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 -$74.4M -$19M -$17.6M -1251% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 -$56.8M -$17.5M -$19.3M -1061% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-26
Q2 2016 -$37.4M -$18.5M -$6.56M -55% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-26
Q1 2016 -$30.9M -$19.4M +$821K +4.07% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-26
Q4 2015 -$31.7M -$1.41M +$17.6M +92.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$49.3M $1.82M +$11M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$60.2M -$11.9M +$7.2M +37.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$67.4M -$20.2M -$1.29M -6.82% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$66.2M -$19M -$1.74M -10.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$64.4M -$9.16M +$11.3M +55.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$75.7M -$19.1M +$1.34M +6.52% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$77.1M -$18.9M +$2.22M +10.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 -$79.3M -$17.2M +$4.44M +20.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$83.7M -$20.5M +$2.24M +9.86% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$86M -$20.5M +$2.02M +8.97% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$88M -$21.1M +$6.48M +23.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$94.5M -$21.7M +$1.15M +5.06% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$95.6M -$22.7M +$6.55M +22.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$102M -$22.5M -$12K -0.05% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$102M -$27.6M +$7.23M +20.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$109M -$22.8M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 -$29.3M +$11.4M +28.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 -$22.5M +$10.2M +31.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 -$34.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 -$40.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$32.7M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.